A leader from a New Zealand-based CRO talks about the countryâs handling of the pandemic, and how their low rates are making sponsors take notice.
The CRO and life-sciences tech firm collaborated on a solution capable of meeting challenges tied to starting and conducting global clinical trials.
The agencyâs Solidarity Therapeutics Trial examined a range of drugs repurposed for COVID-19 treatment, finding nearly no effect on patient mortality.
The clinical research site network has tapped 22-year industry veteran Karri Venn, president of research with LMC Manna, to lead the organization.
The clinical-stage drug development company has kicked off testing the experimental anticancer drug Veyonda on severe patients in a Phase I trial.
Study solutions provider Hū blends behavioral science, decision economics and technology to better integrate the patient voice into clinical research.
eClinical, a provider of clinical data service solutions, has seen an increase in interest in clinical data platform and other digital products.
A veteran with more than 20 years of experience talks about the vitality of recruiting an inclusive patient population, and the perils of falling short.
Neurotrope has kicked off its ongoing Phase II study of Bryostatin-1 for treatment of Alzheimerâs disease, with the help of a $2.7m NIH grant.
Companies like Biofourmis, THREAD and other virtual tech specialists have seen infusions of funds from investors bullish on decentralized clinical trials.
The companyâs Phase II trial of ultramicronized PEA has received FDA approval and expects to begin dosing patientparticipants as early as next month.
The health solutions firm is looking to remote patient monitoring to overcome significant clinical trial obstacles created by the ongoing pandemic.
The companyâs studies exploring the use of opaganib in severe COVID-19 patients have been approved in Brazil and other countries around the globe.
TeleConsent empowers trial teams to obtain informed consent and re-consent from patients participating in clinical studies, within a fully remote system.
The Clinventory inventory management system is designed to help study sponsors streamline management of their clinical trial inventory and supplies.
Results from the research indicate use of ACE in inhibitors and ARBs could prove useful in treating COVID-19 patients of African-American descent.
The AI platform combines machine-learning models and advanced semantic technologies to help life-science users gain insights from their data.
The technology combines predictive analytics and commercial services to help pharma firms and partners maximize drug discovery and development efforts.
The research platform provider will work with the healthcare system to provide GI patients broader diagnostics and treatment.
The CRO will work with the Leukemia and Lymphoma Society on a global master clinical trial to explore treatments for pediatric acute leukemia.
The companies will work together on solutions designed to enable sponsors to improve imaging, respiratory and cardiac safety data on decentralized trials.
The company has released a report revealing how clinical trial professionals are handling start-up, before and after COVID-19 first impacted the industry.
Led by the Spaulding Rehabilitation Hospital, a study by a 60-person task force shows ways mobile health tech can help mitigate the pandemicâs effects.
An online patient community specializing in rare diseases has launched Xperiome, a knowledge platform aimed at speeding development of treatments.
A leader from home-based clinical services firm Illingworth Research Group talks about the evolution of mobile nursing and how it can keep trials going.
The companyâs AI-powered Clinsite investigator site intelligence platform now offers country selection, designed to help streamline trial efficiency.
The cloud-based study technology firm has secured Series B funding to help develop and promote products like its clinical trial platform, StudyTeam.
A partnership between two trial tech providers aims to create a more powerful, efficient and effective study solution for sites, sponsors and CROs.
American Gene Technologies has received the agencyâs approval to launch the first human trial for its lead HIV program, starting in Baltimore and DC.
A leader from the clinical research solutions provider discusses the ways pandemic has shaken the trial industry, and how to tackle the obstacles.
The company is joining with ICER to help promote use of robust, repeatable indirect comparisons in health tech assessments.
Experts from the CRO offers insight on preparing for the changes to the pediatric oncology research requirements, which take effect next week.
A leader from IBM Watson Health talks about how its advanced EDC solution is geared toward helping studies save precious time and conserve costs.
Researchers at ACM Global Laboratories are focused on aiding clinical trials working on treatments for the deadly virus behind the current pandemic.
A leader at the companyâs Acorn AI Labs talks about ways the pandemic has impacted the industry, and how researchers must adapt to a new world.
Use of electronic patient-recorded outcome data can lead to more accurate trial data, and a better patient experience, according to the CRO.
Partnering with Cogstate, the company is seeking to enhance its eCOA solution, with the goal of ultimately boosting the speed and effectiveness of trials.
A representative from the pharma services firm discusses how increasing diversity of clinical trial populations can improve research effectiveness.
Elucid Digital Healthâs Pill Connect is designed to enable CROs and pharma companies to monitor patient adherence during a clinical trial.
The CRO has been tapped by the Frederick National Laboratory for Cancer Research to provide clinical services for an ongoing COVID-19 study
The company has expanded the footprint of the location to accommodate an anticipated increase in the need for COVID-19 vaccine and storage needs.
An industry expert from the global CDMO offers advice on how to plan for a successful clinical trial supply chain, and avoid mistakes along the way.
With the acquisition of HVH Precision Analytics, the company has added new advanced analytics capabilities to its roster of life-sciences services.
A leader from the CRO shares perspectives on the challenges and rewards associated with the category, and approaches in getting generics to market.
The two firms will collaborate on an effort to integrate real-world data into clinical trial technology on a broad range of projects.
A leader with the health data specialists looks at how COVID-19 has impacted the clinical research industry, and what the future of the field might look like.
The clinical development and consulting firm has signed a three-year service agreement to support the pharma firm with development service solutions.
The companies will work together on putting in place technology to facilitate remote monitoring and document review for COVID-19 studies and other research.
The company has opened the doors of a new manufacturing facility designed to create and manufacture a range of wearable drug delivery devices.
A leader from the healthcare solutions firm shares perspective on how application of advanced technologies has driven the evolution of the entire industry.
Using apps and AI technology, Belong.Life brings together cancer patients and current clinical research projects, to further development of therapies.
The UK-based collaboration will include expertise across more than 40 types of cancer, with access to patients from more than 170 referring oncologists.
US FDA’s Coronavirus Treatment Acceleration Program (CTAP): Strategic Considerations for Investigational COVID-19 Drugs, Biologics, and Treatment Vaccines
Click here to download printable PDF The Coronavirus Treatment Acceleration Program (CTAP) is a special emergency program instituted by the US Food and Drug Administration (FDA) in response to the COVID-19 pandemic The primary goal of the program is to expedite the availability of new… Read More »US FDA’s Coronavirus Treatment Acceleration Program (CTAP): Strategic Considerations for Investigational COVID-19 Drugs, Biologics, and Treatment Vaccines
HealthTree is a crowdsourcing platform that enables patients diagnosed with the rare blood cancer to find clinical trials and contribute to a cure.
Enterome completes Series E financing round, with Takeda returning to provide funds to the biotech.
A representative from the clinical trial financial solutions firm tells Outsourcing-Pharma that tech can clear budget-related trial tangles.
The agency has given the thumbs up for Rukobia, a treatment designed for HIV patients facing poor results with current antiretroviral therapies.
The companyâs Beyond platform is designed to give sponsors and CROs an effective, easy-to-operate to manage risks and visualize clinical trial data.
The companyâs Tempod 1000 USB device captures and stores clinical site temperature data automatically for simplified capture and reporting.
Download the white paper now https://bit.ly/evidera-digena Multiple strategies, each with their individual advantages and drawbacks, may be employed to answer a research question, but determining the optimal strategy – the one that will bring you to your answer in the most effective and efficient way possible – that is… Read More »A Systematic Approach to Assessing Real World Research Questions Supported by Digital Enablement